001     296201
005     20250119014824.0
024 7 _ |a 10.1038/s41698-024-00788-3
|2 doi
024 7 _ |a pmid:39794422
|2 pmid
024 7 _ |a pmc:PMC11724059
|2 pmc
024 7 _ |a altmetric:172968539
|2 altmetric
037 _ _ |a DKFZ-2025-00114
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kerle, Irina
|0 P:(DE-He78)d47130d93ccfc7fe3183036680c68c1d
|b 0
245 _ _ |a Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.
260 _ _ |a [London]
|c 2025
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736765718_26799
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Precision oncology offers new cancer treatment options, yet sequencing methods vary in type and scope. In this study, we compared whole-exome/whole-genome (WES/WGS) and transcriptome sequencing (TS) with broad panel sequencing by resequencing the same tumor DNA and RNA as well as normal tissue DNA for germline assessment, from 20 patients with rare or advanced tumors, who were originally sequenced by WES/WGS ± TS within the DKFZ/NCT/DKTK MASTER program from 2015 to 2020. Molecular analyses resulted in a median number of 2.5 (gene panel) to 3.5 (WES/WGS ± TS) treatment recommendations per patient. Our results showed that approximately half of the therapy recommendations (TRs) of both sequencing programs were identical, while approximately one-third of the TRs in WES/WGS ± TS relied on biomarkers not covered by the panel. Eight of 10 molecularly informed therapy implementations were supported by the panel, the remaining two were based on biomarkers absent from the panel, highlighting the potential additional clinical benefit of WGS and TS.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Gross, Thomas
|b 1
700 1 _ |a Kögler, Anja
|b 2
700 1 _ |a Arnold, Jonas
|0 P:(DE-He78)50a972fa9978fdcfc31e1676deccbffe
|b 3
700 1 _ |a Werner, Maximilian
|0 P:(DE-He78)ad0ed5484fb008b6597171a8a348b26f
|b 4
700 1 _ |a Eckardt, Jan-Niklas
|b 5
700 1 _ |a Möhrmann, Elena E
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Arlt, Marie
|0 P:(DE-He78)84169f266ff0c27342b49a59499b4295
|b 7
700 1 _ |a Hutter, Barbara
|b 8
700 1 _ |a Hüllein, Jennifer
|b 9
700 1 _ |a Richter, Daniela
|0 P:(DE-He78)29306fd3ae9f1a9839ed888ebc5c8074
|b 10
700 1 _ |a Schneider, Martin M K
|b 11
700 1 _ |a Hlevnjak, Mario
|b 12
700 1 _ |a Möhrmann, Lino
|0 P:(DE-He78)79e92bc6260b7a24abe4daf4378bf19c
|b 13
700 1 _ |a Hanf, Dorothea
|0 P:(DE-He78)36e79cd7c1ac7dfe060c02dbfdaff3c4
|b 14
700 1 _ |a Heilig, Christoph
|0 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6
|b 15
|u dkfz
700 1 _ |a Kreutzfeldt, Simon
|0 P:(DE-He78)e5972dddc3c8d1412db29ba54fed83ba
|b 16
700 1 _ |a Teleanu, Maria-Veronica
|0 P:(DE-He78)4e4e534b615747750de8b9a7afdd8f56
|b 17
|u dkfz
700 1 _ |a Schröck, Evelin
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Hübschmann, Daniel
|0 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
|b 19
|u dkfz
700 1 _ |a Horak, Peter
|0 P:(DE-He78)5ea1944c122bc098a81df27a05572719
|b 20
|u dkfz
700 1 _ |a Heining, Christoph
|0 P:(DE-He78)1464357f7ec5faf677a390a414e50c88
|b 21
700 1 _ |a Fröhling, Stefan
|0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
|b 22
700 1 _ |a Glimm, Hanno
|0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
|b 23
773 _ _ |a 10.1038/s41698-024-00788-3
|g Vol. 9, no. 1, p. 9
|0 PERI:(DE-600)2891458-2
|n 1
|p 9
|t npj precision oncology
|v 9
|y 2025
|x 2397-768X
909 C O |o oai:inrepo02.dkfz.de:296201
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)d47130d93ccfc7fe3183036680c68c1d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)50a972fa9978fdcfc31e1676deccbffe
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)ad0ed5484fb008b6597171a8a348b26f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)84169f266ff0c27342b49a59499b4295
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)29306fd3ae9f1a9839ed888ebc5c8074
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)79e92bc6260b7a24abe4daf4378bf19c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)36e79cd7c1ac7dfe060c02dbfdaff3c4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)e5972dddc3c8d1412db29ba54fed83ba
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)4e4e534b615747750de8b9a7afdd8f56
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)5ea1944c122bc098a81df27a05572719
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)1464357f7ec5faf677a390a414e50c88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NPJ PRECIS ONCOL : 2022
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T15:13:05Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T15:13:05Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-04-12T15:13:05Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2023-04-12T15:13:05Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NPJ PRECIS ONCOL : 2022
|d 2023-10-27
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-27
920 1 _ |0 I:(DE-He78)DD01-20160331
|k DD01
|l DKTK Koordinierungsstelle Dresden
|x 0
920 1 _ |0 I:(DE-He78)B280-20160331
|k B280
|l B280 Translationale funktionelle Krebsgenomik
|x 1
920 1 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)DD01-20160331
980 _ _ |a I:(DE-He78)B280-20160331
980 _ _ |a I:(DE-He78)B340-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21